Treatment of Severe Atopic Dermatitis With Upadacitinib in Clinical Practice: Short-Term Efficacy and Safety Results

被引：14

作者：

Pereyra-Rodriguez, J. J. ^{[1
,17
]}

Herranz, P. ^{[2
]}

Figueras-Nart, I ^{[3
]}

Perez, B. ^{[4
]}

Elosua, M. ^{[5
]}

Munera-Campos, M. ^{[6
]}

Melgosa-Ramos, J. ^{[7
]}

Zaragoza, V ^{[8
]}

Silvestre, J. F. ^{[9
]}

Campos-Dominguez, M. ^{[10
]}

Guilabert, A. ^{[11
]}

Miquel, J. ^{[12
]}

Alcantara-Luna, S. ^{[13
]}

de la Cueva, P. ^{[14
]}

Serra-Baldrich, E. ^{[15
]}

Armario-Hita, J. C. ^{[16
]}

Rodriguez, Jose Juan Pereyra

机构：

[1] Univ Hosp Virgen Rocio, Dept Dermatol, Seville, Spain

[2] Univ Hosp La Paz, Dept Dermatol, Madrid, Spain

[3] Univ Hosp Bellvitge, Dept Dermatol, Barcelona, Spain

[4] Univ Hosp Ramon & Cajal, Dept Dermatol, Madrid, Spain

[5] Univ Hosp Puerta Hierro, Dept Dermatol, Madrid, Spain

[6] Univ Hosp Germans Trias i Pujol, Dept Dermatol, Badalona, Spain

[7] Univ Hosp Doctor Peset, Dept Dermatol, Valencia, Spain

[8] Univ Hosp Gen Valencia, Dept Dermatol, Valencia, Spain

[9] Univ Hosp Alicante, Dept Dermatol, Alicante, Spain

[10] Univ Hosp Gregorio Maranon, Dept Dermatol, Madrid, Spain

[11] Gen Hosp Granollers, Dept Dermatol, Barcelona, Spain

[12] Univ Hosp Arnau Vilanova, Dept Dermatol, Valencia, Spain

[13] Juan Ramon Jimenez Hosp, Dept Dermatol, Huelva, Spain

[14] Infanta Leonor Hosp, Dept Dermatol, Madrid, Spain

[15] St Pau Hosp, Dept Dermatol, Barcelona, Spain

[16] Univ Hosp Puerto Real, Dept Dermatol, Puerto Real, Spain

[17] Univ Hosp Virgen del Roci, Dept Dermatol, Avda Manuel Siurot S-N, Seville 41013, Spain

来源：

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY | 2023年 / 33卷 / 03期

关键词：

Atopic dermatitis; Atopic eczema; Upadacitinib; JAK-inhibitors; Real-world evidence; DOUBLE-BLIND; ADOLESCENTS; PLACEBO; ADULTS;

D O I：

10.18176/jiaci.0831

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：211 / 213

页数：3

共 50 条

[41] Long-Term Real-World Effectiveness of Dupilumab vs. Upadacitinib in Early Treatment Responders with Atopic Dermatitis: Results from Central European Health Fund Registry [J].

Waligora-Dziwak, Katarzyna ;

Danczak-Pazdrowska, Aleksandra ;

Jenerowicz, Dorota .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (09)

[42] Real-life efficacy and safety of upadacitinib in adolescents with moderate-to-severe atopic dermatitis unresponsive to dupilumab: A case series [J].

Patruno, Cataldo ;

Fabbrocini, Gabriella ;

Potestio, Luca ;

Genco, Lucia ;

Napolitano, Maddalena .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (07) :E901-E903

[43] Network meta-analysis on the efficacy and safety of upadacitinib in adolescents and adults with moderate-to-severe atopic dermatitis [J].

Qiu, Mei ;

Duan, Xue-Yan ;

Yin, Dao-Gen .

INTERNATIONAL JOURNAL OF DERMATOLOGY, 2022, 61 (01) :E24-E26

[44] Efficacy and safety of abrocitinib for the treatment of moderate-to-severe atopic dermatitis: a meta-analysis of randomized clinical trials [J].

Meher, Bikash Ranjan ;

Mohanty, Rashmi Ranjan ;

Padhy, Biswa Mohan .

JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (04) :2335-2343

[45] Long-term efficacy and safety of stapokibart for moderate-to-severe atopic dermatitis: 52-week results from a phase 3 trial [J].

Zhao, Yan ;

Zhang, Litao ;

Wu, Liming ;

Yang, Bin ;

Wang, Jinyan ;

Li, Yumei ;

Li, Jingyi ;

Diao, Qingchun ;

Sun, Qing ;

Zhu, Xiaohong ;

Man, Xiaoyong ;

Wang, Lihua ;

Li, Linfeng ;

Feng, Yanyan ;

Zeng, Huiming ;

Cai, Tao ;

Ren, Hong ;

Lu, Jianyun ;

Lu, Qianjin ;

Tao, Xiaohua ;

Xiao, Rong ;

Ji, Chao ;

Li, Fuqiu ;

Zhang, Jianzhong .

ALLERGY, 2025, 80 (05) :1348-1357

[46] Treatment of Moderate-to-severe Atopic Dermatitis with Upadacitinib: Results from an Interim Analysis of the TREATgermany Registry [J].

Kind, Barbara ;

Heinrich, Luise ;

Werfel, Thomas ;

Schmitt, Jochen ;

Weidinger, Stephan .

ACTA DERMATO-VENEREOLOGICA, 2025, 105

[47] Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults [J].

Xu, Xinghua ;

Zheng, Yi ;

Zhang, Xin ;

He, Yanling ;

Li, Chengxin .

ONCOTARGET, 2017, 8 (65) :108480-108491

[48] Early Achievement of High Treatment Targets in Moderate-to-Severe Atopic Dermatitis with Upadacitinib: Real-World Evidence from the Observational UP-TAINED Study [J].

Weidinger, Stephan ;

Schadeck, Tobias ;

Jacobs, Felix ;

Weyergraf, Ansgar ;

Mortazawi, Dariusch ;

Hagemann, Tobias ;

Abousamra, Fatima ;

Mosch, Thomas ;

Fritz, Bjoern ;

Lauffer, Felix .

DERMATOLOGY AND THERAPY, 2025, 15 (04) :919-931

[49] Upadacitinib treatment withdrawal and retreatment in patients with moderate-to-severe atopic dermatitis: Results from a phase 2b, randomized, controlled trial [J].

Guttman-Yassky, Emma ;

Silverberg, Jonathan I. ;

Thaci, Diamant ;

Papp, Kim A. ;

Staender, Sonja ;

Beck, Lisa A. ;

Kim, Brian S. ;

Hu, Xiaofei ;

Liu, Jianzhong ;

Calimlim, Brian M. ;

Vigna, Namita ;

Crowley, Jameson T. ;

Teixeira, Henrique D. ;

Thyssen, Jacob P. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (12) :2558-2568

[50] Clinical Efficacy and Safety of Upadacitinib Combined With a 308 nm Excimer Laser in the Treatment of Refractory Vitiligo Complicated With Atopic Dermatitis [J].

Zhou, Fangfei ;

Li, Weiye ;

Liu, Yuhang ;

Jin, Qiuyue ;

Han, Wenzhao ;

Li, Jiaqi ;

Liu, Xiang .

DERMATOLOGIC THERAPY, 2025, 2025 (01)

← 1 2 3 4 5 →